Notably, both JUNB and JUND are downregulated in invasive/late (stage 4) melanoma compared to stage 1 melanoma, and several DE genes from stage 1 vs. stage 4 comparison enriched in MAP kinase and Ras GTP binding processes (Table S4.1). The gene discussed is JUND; the disease is melanoma.